(Reuters) -Private equity investors of Foundation Consumer Healthcare, which sells popular morning-after pill Plan B One-Step, are exploring a potential sale of the company, Bloomberg News reported on Wednesday.
The company may seek more than $4 billion, the report said, citing people familiar with the matter.
Stakeholders, including Kelso & Co. and Juggernaut Capital Partners, are working with financial advisers and are at an early stage of deliberations, which may or may not result in a deal, the report said.
The privately-held company, which makes over-the-counter healthcare products, bought Plan B One-Step and other brands of emergency contraception from Israel-based Teva Pharmaceutical Industries in 2017 for $675 million in cash.
Kelso, Juggernaut and Foundation Consumer Healthcare did not immediately respond to Reuters requests for comment.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)
